Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00036205
Status:
TERMINATED
Last Update Posted:
2007-01-18
First Post:
2002-05-08
Brief Title:
Open Label Sumanirole Study of Safety Tolerability and Therapeutic Response In Patients With Parkinsons Disease
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Open-Label Long Term Flexible Dose Study Of Safety Tolerability And Therapeutic Response In Patients With Parkinsons Disease
Status:
TERMINATED
Status Verified Date:
2007-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective is to assess the long term safety and tolerability of sumanirole as measured by safety labs ECG monitoring vital signs and adverse event reports in subjects with Parkinsons Disease who participated in previous sumanirole studies
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None